The Neurobiology of Alzheimer's Disease (Molecular and Cellular Neurobiology Series) 3rd Edition

ISBN-13: 978-0198566618
ISBN-10: 0198566611
Why is ISBN important?
This bar-code number lets you verify that you're getting exactly the right version or edition of a book. The 13-digit and 10-digit formats both work.
Scan an ISBN with your phone
Use the Amazon App to scan ISBNs and compare prices.
Have one to sell?
Loading your book clubs
There was a problem loading your book clubs. Please try again.
Not in a club? Learn more
Amazon book clubs early access

Join or create book clubs

Choose books together

Track your books
Bring your club to Amazon Book Clubs, start a new book club and invite your friends to join, or find a club that’s right for you for free.
Used: Very Good | Details
Condition: Used: Very Good
Comment: Some overall wear from reading, has a few creases.
Access codes and supplements are not guaranteed with used items.
4 used from $89.99
& FREE Shipping
Usually ships within 1 to 3 weeks.
Ships from and sold by BrookBookstore.
Arrives: March 5 - April 1
2 new from $158.53
+ $8.81 shipping

Amazon First Reads | Editors' picks at exclusive prices
click to open popover

Enter your mobile number or email address below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.

  • Apple
  • Android
  • Windows Phone
    Windows Phone
  • Click here to download from Amazon appstore

To get the free app, enter your mobile phone number.


Special offers and product promotions

Editorial Reviews


"Chapters are well chosen and well written...I look forward to future editions."--Physiology News

About the Author

David Dawbarn obtained his PhD from the University of Bristol and then initiated his work on Alzheimer's disease (AD) at the Medical Research laboratories in Cambridge as a Research Fellow. He returned to Bristol to take up a lectureship investigating the molecular pathology of Alzheimer's
disease and developing new therapies. His interests are in nerve growth factor (NGF) and Alzheimer's disease; his early work described the distribution of NGF receptors in the brain, showing their specific localisation on cholinergic neurons. The identity of the NGF binding site on its receptor was
then determined. The domain was made as a recombinant protein, crystallised and its structure solved. The coordinates of the structure are currently being used for the development of small molecule therapeutics for the treatment of Alzheimer's disease. Shelley Allen obtained her PhD at the Institute
of Neurology in London, and her work in the early eighties with David Bowen started her interest in the cholinergic changes in Alzheimer brain. Later at Bristol she investigated the characterisation of human cholinergic basal nucleus in terms of the nerve growth factor (NGF) receptor. She has
continued this work on the neurotrophins and the possibility of a neurotrophin related therapeutic for Alzheimer's disease. In addition she is especially interested in the influence of cholinergic activity on Alzheimer-associated pathogenic processes. Her work recently has also shown variously the
synaptic loss associated with the E4 allele of apolipoprotein E in normal individuals and the increase in BACE activity in sporadic Alzheimer's disease.

Product details

  • Publisher : Oxford University Press; 3rd edition (June 28, 2007)
  • Language : English
  • Hardcover : 536 pages
  • ISBN-10 : 0198566611
  • ISBN-13 : 978-0198566618
  • Item Weight : 2.2 pounds
  • Dimensions : 9.6 x 1.3 x 6.8 inches

Shop our favorite brands
Check out our wide selection of third-party gift cards.
Shop now

Customer reviews

5 star (0%) 0%
4 star (0%) 0%
3 star (0%) 0%
2 star (0%) 0%
1 star (0%) 0%
How are ratings calculated?

No customer reviews